Kezar Life Sciences (KZR) has disclosed a new risk, in the Regulation category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The disclosure directs investors to Part I of Kezar Life Sciences’ filings for a fuller discussion of potential risks and uncertainties beyond those summarized here. This reliance on cross-referenced sections may make it harder for stakeholders to quickly grasp the full scope of risks impacting Kezar’s operations and long-term prospects.
The average KZR stock price target is $7.20, implying -1.23% downside potential.
To learn more about Kezar Life Sciences’ risk factors, click here.